October 2005
|
 |
| Features |
|
|
 |
Update on Tuberculosis |
| |
by John D. Zoidis, MD, and Phyllis C. Braun, PhD |
| |
For patients with TB, chemical quarantine via pharmacotherapy is the modern alternative to isolation in asylums or sanitaria. |
|
|
| |
Antimicrobial Metals |
|
A Nonantibiotic Approach to Nosocomial Infections |
| |
by Kristi L. Farrington, RRT, BCS, CCRC, and Lee E. Morrow, MD |
| |
Silver and copper may prove key in preventing a problem that kills nearly 88,000 per year. |
|
|
|
Drug Delivery by the Respiratory Route: Agents in Development |
| |
by Michael J. Cawley, PharmD, RPh, RRT, CPFT |
| |
Advancements in inhaled pharmaceuticals may even benefit nonrespiratory conditions, such as diabetes. |
|
|
| |
Breathing Easy |
|
The Current State of Lung Simulators |
| |
by Dana Hinesly |
| |
Technological advancements translate to substantial improvements in functionality |
|
|
| |
Innovations in Home Care |
|
O2 to Go |
| |
by John A. Wolfe, RRT, CPFT |
| |
New lightweight concentrators give new freedom to patients dependent on oxygen. |
|
|
|
|
|
|
|
|
|
| Departments |
|
|
|
|
|
 |
|
Resources
